{
  "id": 3263,
  "text": "1204.Giardina, G., et al.Weekly cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer: a welltolerated alternative.Eur $J$ Gynaecol Oncol 18, 173-176 (1997).1205.Lai, C.H., et al.Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1204.Giardina, G., et al.Weekly cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer: a welltolerated alternative.Eur $J$ Gynaecol Oncol 18, 173-176 (1997).1205.Lai, C.H., et al.Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在治疗局部晚期宫颈癌时，每周顺铂作为新辅助化疗是一种具有良好耐受性的选择。这种治疗方案可以在患者接受根治性手术前帮助减小肿瘤体积，提高手术成功率，并改善预后。因此，每周顺铂被认为是辅助治疗的有效化疗方案。",
  "query": "在治疗局部晚期宫颈癌时，哪些化疗方法被认为具有良好的耐受性并可能被用于辅助治疗？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在治疗局部晚期宫颈癌时，哪些化疗方法被认为具有良好的耐受性并可能被用于辅助治疗？\n\n<reference text>: 1204.Giardina, G., et al.Weekly cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer: a welltolerated alternative.Eur $J$ Gynaecol Oncol 18, 173-176 (1997).1205.Lai, C.H., et al.Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在治疗局部晚期宫颈癌时，每周顺铂作为新辅助化疗是一种具有良好耐受性的选择。这种治疗方案可以在患者接受根治性手术前帮助减小肿瘤体积，提高手术成功率，并改善预后。因此，每周顺铂被认为是辅助治疗的有效化疗方案。"
}